Impact of a Pro-diversity Gut Microbiota Diet After a Bariatric Surgery on Gut Microbiota, Eating Behaviour and Sensory Function

NCT ID: NCT07268508

Last Updated: 2025-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-01

Study Completion Date

2029-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Bariatric surgery is the most effective treatment for long-term weight loss and reducing obesity-related health risks. It alters the gastrointestinal tract as well as metabolic and hormonal functions, influencing eating behaviour. However, weight loss outcomes and long-term maintenance vary between patients, likely due to changes in the gut microbiota. Dietary recommendations aimed at improving microbiota diversity could help support sustained weight loss after surgery.

The BariaGut Taste study aims to compare two dietary approaches following bariatric surgery: nutritional counselling promoting gut microbiota diversity versus standard nutritional counselling. One year after surgery, the study will evaluate differences in microbiota diversity, changes in food preferences and eating behaviours, sensory profiles (taste, smell), levels of digestive and gut hormones fasting, before and after eating, cardiometabolic parameters, mental health, physical activity, and more, to better understand Bariatric surgery is the most effective treatment for long-term weight loss and reducing obesity-related health risks. It alters the gastrointestinal tract as well as metabolic and hormonal functions, influencing eating behaviour. However, weight loss outcomes and long-term maintenance vary between patients, likely due to changes in the gut microbiota. Dietary recommendations aimed at improving microbiota diversity could help support sustained weight loss after surgery.

The BariaGut Taste study aims to compare two dietary approaches following bariatric surgery: nutritional counselling promoting gut microbiota diversity versus standard nutritional counselling. One year after surgery, the study will evaluate differences in microbiota diversity, changes in food preferences and eating behaviours, sensory profiles (taste, smell), levels of digestive and gut hormones fasting, before and after eating, cardiometabolic parameters, mental health, physical activity, and more, to better understand the mechanisms that may explain variations in response to bariatric surgery.

The BariaGut Taste study is a prospective, randomized, controlled trial with two parallel groups, involving non-diabetic patients aged 25 to 65 y undergoing either sleeve gastrectomy or Roux-en-Y gastric bypass. The trial will be conducted at the digestive surgery department of Edouard Herriot Hospital, the endocrinology-diabetes-nutrition department of Lyon Sud Hospital Center, and the Human Nutrition Research Center Rhône-Alpes. 60 participants are expected to be recruited, with 30 in each arm.

Participants will be enrolled before surgery during a routine care visit with the surgeon. They will then undergo a metabolic assessment visit conducted exclusively for research purposes. This visit will allow to collect baseline data on primary outcomes via blood, expired air, and stool samples, anthropometric measurements, indirect calorimetry, a battery of questionnaires (TFEQ-21, DEBQ, PHQ-9, SF36, GSES, PANAS, ESUL, BES, DERS, GAD-7, IPAQ, BAQ, GSRS, sensory alterations, Bristol and Likert scales, and FNS), computerized food preference tests (LFPQ), and a standardized, video-recorded ad libitum buffet.

Participants will be followed up at 3, 6, and 12 months after surgery through visits combining clinical care and research assessments. The dietary interventions specific to each group will be provided since the 3-month visit. The assessments conducted before surgery will be repeated at 6 and 12 months, also integrating clinical care objectives.

Additional blood, stool, and adipose tissue samples collected during surgery will be stored to create a biobank.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity (Disorder) Bariatric Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

* Arm with nutritional counselling promoting gut microbiota diversity
* Arm with standard nutritional counselling
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants
Randomisation will be stratified according to sex, type of surgery and age.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants with nutritional counselling promoting gut microbiota diversity

Given the low amounts of food consumed during the first months after surgery, the specific nutritional recommendations for this group will be implemented starting 3 months post-surgery. Before 3 months, participants will receive the standard nutritional recommendations of routine care after bariatric surgery, identical to those given to the second group (see below).

From 3 months onwards, participants will be encouraged to increase the consumption of certain specific foods known for their benefits on the gut microbiota, particularly for promoting gut bacterial diversity, in addition to maintaining protein intake and paying attention to food textures. Summary sheets will be provided to help recall the recommendations.

Group Type EXPERIMENTAL

Nutritional counseling

Intervention Type OTHER

Nutritional counseling

Participants with standard nutritional counselling

The nutritional recommendations given to participants in this group are those applied in routine care within the Endocrinology, Diabetes, and Nutrition (EDN) Department for patients who have undergone sleeve gastrectomy or gastric bypass (Roux-en-Y).

These recommendations aim to maintain adequate protein intake and are adapted to the recent changes in their digestive tract (pureed then mashed food during the first postoperative month). During the first 6 months, patients' food intake is significantly below their nutritional needs. So it is important to pay close attention to hydration (away from meals) and macronutrient intake, especially proteins, as well as the progression of food texture and chewing.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nutritional counseling

Nutritional counseling

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between 25 and 65 years old
* Undergoing either sleeve gastrectomy or Roux-en-Y gastric bypass
* With grade 3 obesity (BMI≥40 kg/m²) or with BMI≥35 kg/m² and at least one comorbidity likely to be improved after surgery, with the exception of type 2 diabetes
* Signed consent form
* Living less than an hour and 30 minutes from the hospital
* Presence of effective and stable contraception for women of childbearing potential

Exclusion Criteria

* Type 2 diabetes
* Presence of a contraindication to bariatric surgery
* Presence of gastrointestinal pathologies with an inflammatory component, known gastroparesis, total gastrectomy, colectomy, exocrine pancreatic insufficiency, known endocrine pathologies inducing hyperglycaemia (uncontrolled dysthyroidism, acromegaly, hypercorticism, etc.), severe chronic renal insufficiency (\< 30mL/min), or hepatocellular insufficiency
* Claustrophobic
* Pregnant or breastfeeding women
* Taking an obesity treatment 3 months before surgery
* Taking a corticoids, immunosuppression, anabolizing, or growing hormones, antibody treatments less than 3 months before inclusion
* Daily taking of laxatives or drugs that can strongly interfere with the composition of the intestinal microbiota. If taken sporadically, the patient can be included at a distance (3 weeks) from the laxatives taken.
* Specific diets (vegetarian, vegan or without gluten)
* No French speaker
* Already included in other study
* Donated blood in the last two months
* Without freezer access
* With allergy or intolerance to food propose in ad libitum buffet
Minimum Eligible Age

25 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Edouard Herriot, digestive surgery department

Lyon, , France

Site Status

Centre de recherche en nutrition humaine de Rhône-Alpes

Pierre-Bénite, , France

Site Status

Hôpital Lyon sud, Endocrinology Diabetes Nutrition department

Pierre-Bénite, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Julie-Anne NAZARE

Role: CONTACT

+33 6 88 87 09 62

Berenice SEGRESTIN

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Maud ROBERT

Role: primary

+33 4 72 11 62 63

Julie-Anne NAZARE

Role: primary

Berenice SEGRESTIN

Role: primary

+33 4 78 86 44 48

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL24_0033

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.